Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNSF.L Regulatory News (NSF)

  • There is currently no data for NSF

Net Asset Value(s)

2 Apr 2007 17:19

Blue Chip Value & Income Fund Ld02 April 2007 The directors of Blue Chip Value and Income Fund Limited today announce that theunaudited Net Asset Value per Ordinary Share based on mid market prices as at 31March 2007 was 36.59 pence. The unaudited Net Asset Value per Ordinary Share based on bid prices as at 31March 2007 was 36.55 pence The unaudited Net Asset Value per Ordinary Share based on bid prices andincluding debt at fair value is 36.54 pence. The interest rate swap has beenvalued using mark to market estimates provided by the counterparty. The directors of Blue Chip ZDP Limited today announce that the unaudited NetAsset Value per Zero Dividend Preference Share as at 31 March 2007 was 163.11pence. Please note that, in accordance with IAS 10, the dividend of 1.00 pence, whichwas announced on 20 February 2007, has not been accrued in the net asset valuesabove as it has not yet been paid. Please note that no estimate of potential wind up costs have been includedwithin the net asset values disclosed above. The breakdown of the portfolio as at 31 March 2007 based on bid prices was Net Cash £34.12 million Bonds £10.25 million Equities £25.44 million Enquiries to: Elysium Fund Management Limited No 1 Le Truchot St Peter Port Guernsey GY1 3JX This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
31st Oct 20174:40 pmRNSSecond Price Monitoring Extn
31st Oct 20174:35 pmRNSPrice Monitoring Extension
20th Oct 201712:06 pmRNSDirector/PDMR Shareholding
9th Oct 20179:57 amRNSHolding(s) in Company
28th Sep 20173:39 pmRNSGeorge Banco receives full FCA authorisation
19th Sep 20172:25 pmRNSHolding(s) in Company
23rd Aug 20177:00 amRNSNotification of Transactions of PDMRs
17th Aug 20173:42 pmRNSCompletion of acquisition of George Banco
11th Aug 20171:13 pmRNSHardman Research: H117 Delivering growth options
4th Aug 20177:00 amRNSDirector/PDMR Shareholding
3rd Aug 20177:01 amRNSAcquisition of George Banco, £225m term loan & RCF
3rd Aug 20177:00 amRNSUnaudited half year results to 30 June 2017
26th Jul 20173:01 pmRNSNotice of Results
25th Jul 20174:35 pmRNSPrice Monitoring Extension
5th Jun 20177:00 amRNSAppointment of joint broker
17th May 20177:00 amRNSLoans at Home receives full FCA authorisation
10th May 20172:52 pmRNSHolding(s) in Company
9th May 201712:50 pmRNSResult of AGM
9th May 20177:00 amRNSAGM Trading update
4th May 20172:02 pmRNSDirectorate Change
4th May 201711:03 amRNSHolding(s) in Company
3rd May 20171:51 pmRNSHolding(s) in Company
3rd May 20178:39 amRNSHolding(s) in Company
19th Apr 20174:52 pmRNSHolding(s) in Company
18th Apr 201712:41 pmRNSHolding(s) in Company
10th Apr 20172:55 pmRNSAnnual Financial Report
17th Mar 20177:00 amRNSExtension of Existing Bank Facilities
15th Mar 20173:46 pmRNSNotification under Listing Rule 9.6.14(2)
13th Mar 201710:42 amRNSHardman Research: Branching Out Invest Accelerated
3rd Mar 201712:45 pmRNSTimetable for final dividend
3rd Mar 20177:00 amRNSFinal Results
28th Feb 20178:00 amRNSMarket developments in home-collected credit
17th Jan 20177:00 amRNSPre-Close Trading Update
13th Jan 20174:40 pmRNSSecond Price Monitoring Extn
13th Jan 20174:35 pmRNSPrice Monitoring Extension
19th Dec 20169:30 amRNSDirectorate Change
1st Dec 20169:25 amRNSDirector/PDMR Shareholding
1st Dec 20169:25 amRNSDirector/PDMR Shareholding
29th Nov 20168:58 amRNSFCA review of high-cost credit and overdrafts
15th Nov 20164:25 pmRNSDirector/PDMR Shareholding
11th Nov 201610:05 amRNSHardman Research: "Carpe Diem"
10th Nov 20164:40 pmRNSSecond Price Monitoring Extn
10th Nov 20164:35 pmRNSPrice Monitoring Extension
1st Nov 20167:00 amRNSInvestor day and trading update
31st Oct 201611:10 amRNSDirectorate Change
27th Oct 201611:55 amRNSHolding(s) in Company
5th Sep 201611:48 amRNSTotal Voting Rights
4th Aug 201612:07 pmRNSSecond Price Monitoring Extn
4th Aug 201612:02 pmRNSPrice Monitoring Extension
3rd Aug 20167:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.